Conditions: Esophageal Cancer
Intervention Type: Drug
Intervention Name: Topotecan and pegylated doxorubicin
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "Topotecan and pegylated doxorubicin" on "Esophageal Cancer".
-
GSK - Doublet: A Phase I Study of Pegylated Liposomal Doxorubicin (Doxil) and Weekly Intravenous Topotecan in Patients With Advanced Solid Tumors
NCTID: NCT00252889
